Cargando…
Imaging Features of Retinal Vasculitis and/or Retinal Vascular Occlusion after Brolucizumab Treatment in the Postmarketing Setting
PURPOSE: The aim of this analysis was to characterize the spectrum of inflammatory changes arising from brolucizumab use in routine clinical practice. DESIGN: Retrospective analysis of fluorescein angiography (FA), fundus photography (FP) and OCT images taken at the time of adverse event. SUBJECTS:...
Autores principales: | Grewal, Dilraj S., Wykoff, Charles C., D’Souza, Divya, Jehl, Valentine, Alecu, Iulian, Jaffe, Glenn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587630/ https://www.ncbi.nlm.nih.gov/pubmed/37869023 http://dx.doi.org/10.1016/j.xops.2023.100361 |
Ejemplares similares
-
Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration
por: Haug, Sara J., et al.
Publicado: (2020) -
Trends in the Cumulative Post-Marketing Reporting Rates of Retinal Vasculitis and/or Retinal Vascular Occlusion and Associated Vision Loss with Brolucizumab
por: Igwe, Franklin, et al.
Publicado: (2022) -
RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence
por: Wykoff, Charles C., et al.
Publicado: (2023) -
Retinal arterial occlusive vasculitis after multiple intravitreal brolucizumab injections for diabetic macular edema
por: Hirano, Takao, et al.
Publicado: (2022) -
Angiographic findings before and after the onset of brolucizumab-associated retinal vascular occlusion and intraocular inflammation
por: Kusuhara, Sentaro, et al.
Publicado: (2022)